← Back
▲ BUY
5 / 10

Conviction

$ Value

$221

Shares

362

Price

$1

Filed

Nov 26

Why this score? (5/10)
  • Open market buy (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Yu Jeffrey

Title

Chief Medical Officer

CIK

0001991132

Roles

Director Officer

Transaction Details

Transaction Date

2024-01-17

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,462,291

Footnotes

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.28 to $1.31, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnotes of this report. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.35 to $1.37, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.09, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.82 to $0.85, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.71 to $0.78, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.56 to $0.73, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.62, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.62, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.48 to $0.54, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.52 to $0.60, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.50 to $0.60, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.51 to $0.60, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.07, inclusive. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.48, inclusive. | Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024. | The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.

Filing Info

Accession No.

0001493152-25-025269

Form Type

4

Issuer CIK

0001849380

Yu Jeffrey's History

Date Ticker Type Value
2025-11-26 ONMD A $0
2025-11-24 ONMD A $0
2025-09-25 ONMD $1K
2025-09-24 ONMD $18K
2025-09-23 ONMD $5K
2025-09-22 ONMD $380
2025-09-19 ONMD $1K
2025-09-18 ONMD $637
2025-09-05 ONMD $2K
2025-09-04 ONMD $10K

Other Insiders at ONMD (90d)

No other insider activity at this issuer in the last 90 days.